Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new aldara clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on aldara
- Vaccine Therapy With or Without Montanide ISA-51 and/or Imiquimod in Treating Patients With Melanoma That Has Been Removed By Surgery
Status: Recruiting, Condition Summary: Melanoma (Skin) - Imiquimod 5% Cream in Plaque-Type Morphea: A Pilot, Prospective Open-Label Study
Status: Withdrawn, Condition Summary: Morphea - Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
Status: Recruiting, Condition Summary: Genital Warts - Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
Status: Completed, Condition Summary: Cutaneous Leishmaniasis - Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin
Status: Recruiting, Condition Summary: Melanoma (Skin); Metastatic Cancer - Imiquimod in Children With Plaque Morphea
Status: Recruiting, Condition Summary: Scleroderma, Localized - Daclizumab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia
Status: Recruiting, Condition Summary: Brain and Central Nervous System Tumors - Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva
Status: Recruiting, Condition Summary: Vulvar Cancer - Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
Status: Active, not recruiting, Condition Summary: Melanoma (Skin) - Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer
Status: Active, not recruiting, Condition Summary: Non-Melanomatous Skin Cancer - Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
Status: Active, not recruiting, Condition Summary: Cervical Cancer - Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer
Status: Active, not recruiting, Condition Summary: Non-Melanomatous Skin Cancer - Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year
Status: Active, not recruiting, Condition Summary: Actinic Keratoses - Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses
Status: Completed, Condition Summary: Keratosis; Actinic Keratosis - Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients
Status: Recruiting, Condition Summary: Malignant Melanoma - Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks
Status: Enrolling by invitation, Condition Summary: Port Wine Stain - Topical Imiquimod for Bowen's Disease of the Head and Neck
Status: Enrolling by invitation, Condition Summary: Bowens Disease - Optimization of UV Radiation Therapy in Psoriasis
Status: Not yet recruiting, Condition Summary: Psoriasis - Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
Status: Active, not recruiting, Condition Summary: Actinic Keratoses - Prospective Randomized Trial: Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas
Status: Recruiting, Condition Summary: Carcinoma, Basal Cell - Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal
Status: Recruiting, Condition Summary: Healthy - Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
Status: Active, not recruiting, Condition Summary: Actinic Keratosis - A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma
Status: Completed, Condition Summary: Basal Cell Carcinoma - A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy
Status: Completed, Condition Summary: Hemangioma, Capillary - Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients
Status: Recruiting, Condition Summary: Chronic Lymphocytic Leukemia - Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Status: Completed, Condition Summary: Keratosis - Intron-A/Aldara Combination Therapy For BCC
Status: Recruiting, Condition Summary: Basal Cell Carcinoma Excluding Scalp and Face - NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)
Status: Completed, Condition Summary: Malignant Melanoma - Viral Load Determination and Biomarkers of High Risk HPV-Types in HIV-Positive Men
Status: Recruiting, Condition Summary: HIV Infections; Papillomavirus Infections; Anal Intraepithelial Neoplasia - Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts
Status: Recruiting, Condition Summary: Genital Warts